Precision Health Research, Singapore (PRECISE)

Learn more about PRECISE.

Last updated on 21 August 2026

Six purple circles form a grid above the text "PRECISE Precision Health Research Singapore".

Precision Health Research, Singapore (PRECISE) is the central entity set up to coordinate a whole-of-government effort to implement Singapore’s three-phase National Precision Medicine (NPM) programme.

NPM Phase II sequenced 100,000 Singaporeans and conducted clinical implementation studies, linking genomic, lifestyle, and healthcare data to deepen understanding of Asian diseases.

Four individuals sit around a table with laptops and papers in an office with glass walls and sticky notes.

NPM Phase III programme reflects the shared commitment of PRECISE and Singapore’s three public healthcare clusters to work together and enrol about 10% of Singapore's local resident population as study participants by 2030.

Conducted as a large-scale research initiative, NPM Phase III will generate robust, population-specific evidence to analyse the cost and effectiveness of using genomic information in healthcare when scaled beyond pilots to population levels. These insights will help guide how genomic information could, in future, be responsibly integrated into healthcare to support physicians and patients in preventive and more targeted care.

For more information, please visit the PRECISE website (opens in new tab).